Earnings call Embecta reported a challenging Q2 2026 with revenue down 14.4% YoY (as-reported) and 17.4% (constant currency), driven by U.S. pen needle share loss and market softness. Full-year ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Embecta (NASDAQ:EMBC) President and CEO Devdatt Kurdikar said the company's recent U.S. business reset reflected a combination of customer-specific share loss, softer market trends and ...
Earlier this year it appeared that Embecta, a diabetes care company that spun off from BD in 2022, was finally back on track after a rocky 2025. The Parsippany, NJ-based company’s fiscal ...
Embecta’s latest earnings call balanced long-term strategic steps with stark near-term pain. Management touted the Owen Mumford acquisition, GLP‑1 partnerships, and solid liquidity, yet the discussion ...
Welcome, ladies and gentlemen, to Embecta Corp.'s fiscal second quarter 2025 earnings conference call. At this time, all participants have been placed in a listen-only mode. Please note that this ...
Welcome, ladies and gentlemen, to Embecta Corp.'s Fiscal Third Quarter 2025 Earnings Conference Call. [Operator Instructions] Please note that this conference call is being recorded, and a replay will ...
Embecta (NASDAQ:EMBC) President and CEO Devdatt Kurdikar said the company’s recent U.S. business reset reflected a combination of customer-specific share loss, softer market trends and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results